JANX (STOCKS)
Janux Therapeutics, Inc. Common Stock
$17.320000
+0.190000 (+1.11%)
Prev close: $17.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David Campbell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,057.06M
- Employees
- 103
- P/E (TTM)
- -10.42
- P/B (TTM)
- 1.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
10
Strong Buy
12
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.35 | $-0.39 | +0.0420 | +10.71% |
|
Mar 2026 (Q1)
|
$-0.39 | $-0.54 | +0.1469 | +27.36% |
|
Dec 2025 (Q4)
|
$-0.51 | $-0.66 | +0.1471 | +22.39% |
|
Sep 2025 (Q3)
|
$-0.39 | $-0.63 | +0.2397 | +38.07% |